NRLE FORM - 11

La Salle University
College of Nursing
Ozamiz City

DRUG STUDY
DRUG NAME ROUTE/DOSAGE/ INDICATION MECHANISM OF CONTRAINDICATION SIDE NURSING
FREQUENCY ACTION EFFECTS RESPONSIBILITY
/
PATIENT
TEACHING
Generic Name: The management Blocks the action of se rotoni n 5- o Children younger than 4
of nausea and HT3 receptor sites years old 1. Instruct
Ondansetron Route: vomiting CNS: patient to report
hydrochloride PO, IV, IM and o Serotonin 5-HT3 o Hypersensitivity to dizziness, any problems
Rectal o induced by receptor sites are Ondansetron or any of its fatigue with breathing.
Brand Name: cytotoxic present on vagal components
Dosage: chemother nerve terminals and CV: chest 2. Monitor liver
Zofran apy, certain areas of the o Patient is also taking pain, function tests
2mg/mlinjectable o for the brain Apomorphine arrhythmias Don’t exceed 8
Pharmacologic Class: solution; 4mg, prevention o Serotonin s-HT3 mg in patients
8mg, 24mg and antagonists bind to Respiratory: with hepatic
Serotonin 5- HT3 Receptor tablets; 4mg, treatment the s-HT3 receptors hypoxia impairment.
Antagonist 8mg, oral of post- sites to suppress
disintegrating operative vomiting and nausea 3. Tell patient to
Therapeutic Class: tablet; 4mg, 8mg nausea and o The binding of these report
oral dissolving vomiting antagonists to 5-HT3 discomfort at
Anitemetics film; 2mg/5ml (PONV) inhibits serotonin injection site
oral solution o for the from eliciting its
prevention effects
Frequency: of nausea
and
4 mg IV push vomiting

LA SALLE UNIVERSITY COLLEGE OF NURSING : Drug Study 2019

 every 6 hours for associated
nausea and with
vomiting radiotherap
Picture: y, either
total body
irradiation
or single
high dose
fraction to
the
abdomen.

LA SALLE UNIVERSITY COLLEGE OF NURSING : Drug Study 2019

 Submitted by: Submitted to:

Name of Student: Jobert P. Rosillosa Mrs. MaryVic Regalado, MN

Year Level: BSN - 3 Name of Clinical Instructor
Date: October 27, 2021 Date: October 27, 2021

LA SALLE UNIVERSITY COLLEGE OF NURSING : Drug Study 2019